Schemes of discontinuation of NOACs. | Download Table
REVISED Anticoagulation module 4: clinical aspects of anticoagulation - The British Journal of Cardiology
Direct Oral Anticoagulants in Patients With Active Cancer: A Systematic Review and Meta-Analysis - ScienceDirect
Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association | Circulation
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library
![PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6650714338788ce610c0f562e51869ceb57aaf9/1-Table1-1.png "PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar")
PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar
Comparison of upper gastrointestinal bleeding risk in users of warfarin... | Download Scientific Diagram
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
NOAC FAQs – Mitigation and management of the bleeding risk #2
Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction | SpringerLink
![Bleeding risk of elective surgeries, adapted from [30] | Download Table](https://www.researchgate.net/publication/330714098/figure/tbl3/AS:720463462412288@1548783283001/Bleeding-risk-of-elective-surgeries-adapted-from-30.png "Bleeding risk of elective surgeries, adapted from [30] | Download Table")
Bleeding risk of elective surgeries, adapted from [30] | Download Table
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Cancers | Free Full-Text | Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools | HTML
Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding: A nationwide cohort study - Heart Rhythm
Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study - Thrombosis Research
Comparison of NOACs in risk of major bleeding in patients with AF. AF =... | Download Scientific Diagram
Novel Oral Anticoagulants (NOACs) Roundtable: Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review | AER Journal
![PDF] Evaluation of bleeding in patients receiving direct oral anticoagulants | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9db6e642899d84004f326bfb36596a5d9dc23cf3/14-Table5-1.png "PDF] Evaluation of bleeding in patients receiving direct oral anticoagulants | Semantic Scholar")
PDF] Evaluation of bleeding in patients receiving direct oral anticoagulants | Semantic Scholar
Comparison of each NOAC and warfarin in risk of major bleeding in... | Download Scientific Diagram
Comparison of the NOACs -Pharmacokinetics. | Download Table
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation - Heart Rhythm
